Patients with hypersensitivity to albumin are not eligible
Calcium >= LLN (corrected for serum albumin, if albumin abnormal)
Serum albumin >= 30 g/L
Serum albumin >= 2.5
Albumin > 25 g/L
Within 14 days of randomization: Albumin > 30 g/L
Albumin >= 3.0.
Serum albumin concentration ?30 g/L
Albumin > 25 g/L
Patients with albumin allergy
Serum albumin > 28 g/L
Albumin < 2.5
Albumin > 25 g/L
Albumin > 3.0
Baseline serum albumin > 30 g/L
Hypoalbuminaemia (serum albumin < 30 g/L)
Calcium >= LLN (corrected for serum albumin, if albumin abnormal) =< 14 days prior to registration\r\n* NOTE: Supplementation may be given before the first dose of study medication
Serum albumin >= 28 g/L
Total calcium (corrected for serum albumin if albumin abnormal) above lower limit normal range for the institution; supplementation may be given before the first dose of study medication
Albumin within institutional normal range
Albumin >= 2
Serum albumin > 30 g/L, or serum albumin = 30 g/L but normal prothrombin time
Albumin <2.8
Albumin > 25 g/L
Albumin >= 3.0
Serum albumin ? 30 g/L
Serum albumin ?3.2 g/dL in the absence of receipt of (IV) albumin within the previous 72 hours.
Albumin should be >= 3
Known hypersensitivity to human albumin
Albumin > 25 g/L
Serum albumin >= 3.0
Albumin < 3.5
Urinary albumin > 1 g/day
Serum albumin < 3.0
Albumin > 3.4
Albumin within 2 x ULN
Serum albumin >= 30 g/L
Albumin >= 3.2 g/dL (in the absence of receipt of intravenous albumin in the previous 72 hours)
Serum albumin must be planned to be collected after admission, but prior to treatment
Serum albumin <25 gram per liter (g/L)
